The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...

NFL Draft is still more than three months away, but the current owner of the No. 1 overall pick has already stirred the drama ...

The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...

The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...

The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...